Cargando…

Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Schuler, Charles, O'Shea, Kelly, Gherasim, Carmen, Manthei, David, Chen, Jesse, Zettel, Cristyn, Troost, Jonathan, Kennedy, Andrew, Tai, Andrew, Giacherio, Don, Valdez, Riccardo, Baldwin, James, Baker, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804460/ http://dx.doi.org/10.1016/j.jaci.2021.12.352

Ejemplares similares

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
por: Schuler, Charles F., et al.
Publicado: (2021)

Vaccination against COVID-19 Leads to Enhanced Immunity Despite Infection History
por: O'Shea, Kelly, et al.
Publicado: (2022)

Accurate point-of-care serology tests for COVID-19
por: Schuler, Charles F., et al.
Publicado: (2021)

Viral Neutralization Against SARS-CoV-2 is More Durable After Infection Versus Vaccination
por: Chen, Kelsea, et al.
Publicado: (2023)

Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
por: O’Shea, Daniel, et al.
Publicado: (2023)

Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing
por: O’Shea, Kelly M., et al.
Publicado: (2023)

Does Point-Of-Care SARS-CoV-2 Antibody Testing Have Similar Sensitivity and Specificity To High Complexity Serology?
por: O'Shea, Kelly, et al.
Publicado: (2021)

Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples
por: Manthei, David M, et al.
Publicado: (2020)

Point-of-care assays can detect COVID-19 antibodies via serum or whole blood
por: Schuler, Charles, et al.
Publicado: (2021)

Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes
por: Schuler, Charles F., et al.
Publicado: (2023)

Spike-Timing Dependent Plasticity and the Cognitive Map
por: Bush, Daniel, et al.
Publicado: (2010)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Dual Coding with STDP in a Spiking Recurrent Neural Network Model of the Hippocampus
por: Bush, Daniel, et al.
Publicado: (2010)

Metagenomic Assay for Identification of Microbial Pathogens in Tumor Tissues
por: Baldwin, Don A., et al.
Publicado: (2014)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies
por: Lester, Sandra, et al.
Publicado: (2019)

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
por: Graninger, Marianne, et al.
Publicado: (2023)

Orthobunyavirus spike architecture and recognition by neutralizing antibodies
por: Hellert, Jan, et al.
Publicado: (2019)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus
por: Chan, C.M., et al.
Publicado: (2009)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays
por: Passariello, Margherita, et al.
Publicado: (2023)

Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
por: Whiting, Gail, et al.
Publicado: (2012)

Motif statistics and spike correlations in neuronal networks
por: Hu, Yu, et al.
Publicado: (2012)

FVIII inhibitors display FV‐neutralizing activity in the prothrombin time assay
por: Arsiccio, Andrea, et al.
Publicado: (2021)

Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
por: Tantiwiwat, Termsak, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
por: Huo, Jiandong, et al.
Publicado: (2020)

Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus
por: Chen, Rui, et al.
Publicado: (2020)

The effect of spike mutations on SARS-CoV-2 neutralization
por: Rees-Spear, Chloe, et al.
Publicado: (2021)

Structures of Omicron spike complexes and implications for neutralizing antibody development
por: Guo, Hangtian, et al.
Publicado: (2022)

Neutralization of the new coronavirus by extracting their spikes using engineered liposomes
por: Zhang, Zhenjiang, et al.
Publicado: (2023)

Titration and neutralizing antibody quantification by focus forming assay for Powassan virus
por: Stone, E. Taylor, et al.
Publicado: (2022)

Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies
por: Feng, Yu, et al.
Publicado: (2016)

A cell-based assay for the detection of neutralizing antibodies against alemtuzumab
por: Ali, Liaqat, et al.
Publicado: (2020)

A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells
por: Pısıl, Yalçın, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r448s13ovtqntiot63di7706n8